Shenzhen Neptunus Intrlng Bi tchnq CoLtd  

(Public, HKG:8329)   Watch this stock  
Find more results for 8329
0.000 (0.00%)
May 26 - Close
HKG data delayed by 15 mins - Disclaimer
Currency in HKD
Range     -
52 week 0.43 - 0.65
Open     -
Vol / Avg. 0.00/309,310.00
Mkt cap 788.66M
P/E 10.76
Div/yield     -
EPS 0.04
Shares 426.00M
Beta     -
Inst. own     -

Key stats and ratios

Q1 (Mar '17) 2016
Net profit margin 8.90% 9.59%
Operating margin 11.68% 12.46%
EBITD margin - 14.52%
Return on average assets - 6.78%
Return on average equity - 11.03%
Employees 1,251 -
CDP Score - -


1F, Block 1, Research Building Neptunus Technical Center
+86-755-26411869 (Phone)
+86-755-86391610 (Fax)

Website links


Shenzhen Neptunus Interlong Bio-Technique Company Limited is a Hong Kong-based company principally engaged in the development, production and sales of medicines. The Company operates through three segments. Medicines segment is engaged in the manufacture and sales of medicines. Medicines and Healthcare Products segment is engaged in the sales and distribution of medicines and healthcare products. Research and Development Services of Modern Biological Technology segment is engaged in the provision of research and development services of modern biological technologies, such as in vitro diagnostics reagents businesses. The products of the Company include herbal medicines, generic drugs, transfusion and anti-tumor drugs, among others. The Company mainly operates businesses in China.

Officers and directors

Feng Zhang Executive Chairman of the Board, Compliance Officer
Yan He Xu General Manager, Executive Director
Age: 59
Ling Xia Mu Joint Company Secretary, Financial Controller
Age: 46
Man Chao Wang Executive General Manager - Jiangsu Neptunus
Age: 37
Hang Yuan General Manager - Neptunus Nano
Age: 39
Mei Yi Lee Joint Company Secretary
Age: 48
Zhan Jun Liu Non-Executive Director
Ting Jiu Song Non-Executive Director
Age: 59
Lin Yu Non-Executive Director
Age: 58
Wen Liang Zhao Non-Executive Director
Age: 40